The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thanks for your reply Porschefund. Appreciate it.
Gr33ning68 - This is the extract from the Dec '17 Admission Document:
The new Ordinary Shares to be issued to the holders of the SSNs and the Second Bilateral Facility pursuant to the Capital Restructuring (please refer to the Transaction Overview in Part 2 of this document for further details) will be subject to lock-in provisions that will restrict transfers of such shares for a period of six months from their date of issuance without Savannah’s prior consent in order to ensure an orderly market in the Ordinary Shares.
Sorry to ask this question guys but I'm confused. Are the shares subject to a 6 month lock in or free to be traded?
True olderandwiser - however short termers just lost 10% and long termers just lost 10% (on paper) - wish I was buying now and getting more shares for my money - but as you say it does depend on your time frame - hoping we are going to hit 35p in the next 3 months myself so plenty of time for this to settle down and a decent uptrend to start - there will be some who need to get out right now which is where downward pressure has come from. I admit that I topped up too soon but this is AIM and you never can tell for sure what is going to happen.
All depends on your time frame for investing.
As previously anticipated, 116,638,985 new Ordinary Shares have been issued in aggregate as part of the Transaction completion process (the "Consideration Shares").
Application for the admission to trading on AIM of 90,666,308 Consideration shares has been made and is expected to become effective at 8.00 a.m. on 18 November 2019. Application for admission to trading on AIM will be made for the 25,972,677 remaining Consideration Shares and it is expected that such admission will take effect at 8.00 a.m. on or around 21 November 2019.
that is a bit of an overhang and very off putting